Jun Lu

Dr. Jun Lu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HZHanzhang Zhu
Hanzhang Zhu
WZWeijiang Zhou
Weijiang Zhou
YWYafeng Wan
Yafeng Wan
JLJun Lu
Jun Lu
KGKe Ge
Ke Ge
CJChangku Jia
Changku Jia
Pancreatic cancer is one of the most lethal malignant tumors. However, the molecular mechanisms responsible for its progression are little known. This study aimed to understand the regulatory role of CD44V3 in pancreatic cancer. A Kaplan–Meier analysis was performed to reveal the correlation between CD44/CD44V3 expression and the prognosis of pancreatic cancer patients. CD44V3 and U2AF1 were knocked down using shRNAs. The proliferation, migration, invasion, and stemness of two pancreatic cell lines, BxPC-3 and AsPC-1, were examined. The expression of CD44V3, cancer-associated markers, and the activation of AKT signaling were detected by qRT-PCR and Western blot. Both CD44 and CD44V3 expression levels were associated with a poor prognosis in pancreatic cancer patients. Interestingly, the expression of CD44V3, instead of CD44, was greatly increased in tumor tissues. CD44V3 knockdown inhibited the proliferation, migration, invasion, and stemness of cancer cells. CD44V3 splicing was regulated by U2AF1 and downregulation of U2AF1 enhanced CD44V3 expression, which promoted pancreatic cancer progression. CD44V3 is an important cancer-promoting factor, which may serve as a potential candidate for pancreatic cancer intervention.

23 February 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
JLJun Lu
Jun Lu
WZWeijiang Zhou
Weijiang Zhou
XWXuyong Wei
Xuyong Wei
KWKai Wang
Kai Wang
LZLixin Zhou
Lixin Zhou
XXXiao Xu
Xiao Xu
Although clear cell renal cell carcinoma (ccRCC) is easy to diagnose early and most can be radically resected, nearly one-third of patients still experience metastases after radical nephrectomy. The most common distant metastases sites of ccRCC are lung, bone and liver. However, periampullary metastasis of ccRCC is very rare and easy to misdiagnose. A 59-year-old male patient was hospitalized for recurrent hematochezia. He had a history of nephrectomy 16 years ago due to ccRCC. Enhanced upper abdominal computed tomography (CT) suggested a mass in the ampulla of vater, and active hemorrhage of duodenal papilla was observed by endoscopy. He underwent an emergency pancreaticoduodenectomy because endoscopic hemostasis and transcatheter arterial embolization (TAE) both failed. Intraoperatively, we found that the tumor located in the ampulla and invaded the pancreatic tissue. The operation was successful, with no postoperative complications. Postoperative pathology suggested metastatic ccRCC.

10 February 2026 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
LZLixin Zhou
Lixin Zhou
QYQijun Yang
Qijun Yang
WZWeijiang Zhou
Weijiang Zhou
YLYingzi Li
Yingzi Li
XZXiaofeng Zhang
Xiaofeng Zhang
JLJun Lu
Jun Lu

28 March 2026 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
JLJun Lu
Jun Lu
JZJin-Hui Zhu
Jin-Hui Zhu
Hepatic Epstein-Barr virus-positive inflammatory follicular dendritic cell sarcoma (EBV+IFDCS) is an extremely rare low-grade malignant tumor. Due to its r